Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.905 USD | -6.75% | -4.86% | +13.19% |
04-24 | Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Amid Earnings Deluge | MT |
04-24 | Centessa Pharmaceuticals Prices Equity Offering at $9.25 Per ADS | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.19% | 1.06B | |
+17.82% | 47.02B | |
+48.77% | 41.86B | |
+0.56% | 41.76B | |
-4.27% | 28.8B | |
+12.05% | 26.05B | |
-21.16% | 19.15B | |
+4.48% | 12.55B | |
+28.52% | 12.34B | |
-4.33% | 11.82B |
- Stock Market
- Equities
- CNTA Stock
- News Centessa Pharmaceuticals plc
- Goldman Sachs Adjusts Price Target on Centessa Pharmaceuticals to $5 From $4.50, Maintains Neutral Rating